ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 4 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$780,000205,3700.00%
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q2 2020.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders